Accure Therapeutics is an R&D-driven biopharmaceutical company focused on developing innovative medicines for patients suffering from central nervous system diseases, one of the world’s greatest unmet medical challenges. Based in Barcelona, the company integrates cutting-edge neurobiology and translational science to design first-in-class therapies capable of modifying disease progression rather than merely alleviating symptoms.

Accure’s scientific approach builds on deep understanding of neurodegeneration and neuroinflammation at the genetic, molecular, and cellular levels. Its discovery programs target mechanisms underlying brain disorders such as acute optic neuritis, multiple sclerosis, Parkinson’s disease, and post-traumatic epilepsy.

With a seasoned team of neuroscientists and entrepreneurs, Accure Therapeutics aims to deliver medicines that matter — restoring function, improving quality of life, and transforming how CNS disorders are treated.